Trials / Not Yet Recruiting
Not Yet RecruitingNCT06898177
Development and Testing of a Mobile App to Scale Delivery of Cognitive-behavioral Therapy for Avoidant/Restrictive Food Intake Disorder
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Avoidant/restrictive food intake disorder (ARFID) is a serious and impairing eating disorder - occurring in up to 4% of adults - for which most individuals do not have access to treatment. The proposed study aims to develop and test a mobile app to scale delivery of cognitive-behavioral therapy for ARFID. Knowledge gained will contribute to the development of a clinically accessible, scalable, inexpensive treatment for ARFID, a highly impairing disorder for which there are significant barriers to care access.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | mCBT-AR | mCBT-AR is an 8-week virtual treatment for avoidant/restrictive food intake disorder delivered via mobile application |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2030-04-01
- Completion
- 2030-04-01
- First posted
- 2025-03-27
- Last updated
- 2025-04-04
Source: ClinicalTrials.gov record NCT06898177. Inclusion in this directory is not an endorsement.